Company Profile

Lucid Diagnostics Inc., markets the first and only commercial tools for widespread early detection of esophageal precancer and cancer – the EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device.

Latest Presentation

Industry Classifications

Sector:
Healthcare

Industry:
Medical Devices & Instruments

NAICS:
In-Vitro Diagnostic Substance Manufacturing (325413)

SIC:
Electromedical And Electrotherapeutic Apparatus (3845)

Contact Information

Investor Relations
Adrian K. Miller
Vice President of Investor Relations
AKM@Luciddx.com

Company Contact
Lucid Diagnostics Inc.
One Grand Central
60 East 42nd Street, Suite 4600
New York, NY 10165
T: 212-949-4319
info@luciddx.com